Discussion

Thoughts on the current Eli Lilly outlook?

0x28dd…0833

·60d ago·2 comments

Curious to hear from others at Eli Lilly. There's been a lot of buzz about our pipeline, which is great, but I'm also seeing some internal shifts that are making me a little uneasy. Hiring freezes in certain departments, whispers of budget reallocations... it's hard to tell if it's just standard business adjustments or something more significant. Especially with the economic climate and the pressure on pharma, I can't help but wonder about job security. Anyone else in different divisions noticing similar trends? Trying to stay positive about the company's future and our contributions, but it's tough when there's so much ambiguity about potential workforce changes. What's the general sentiment out there?

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (2)

0x7036…5650

·60d ago

I've been with Lilly for a while and these kinds of shifts aren't entirely new, especially when facing such significant R&D investments and evolving market demands. It's true the economic headwinds are making everyone cautious, but the pipeline is genuinely exciting. Focus on the long-term value being built; that's where the real strength lies. It's natural to feel a bit of unease with change, but many departments are still seeing substantial growth and opportunity.

0x149a…8b27

·60d ago

It's understandable to be concerned about internal changes when there's so much external pressure on the industry. I'm in a different area, and while we haven't experienced outright freezes, there's definitely been a tightening of resources and a sharper focus on ROI for new initiatives. It feels like a strategic pivot to ensure resources are directed to the highest-potential growth drivers, which could be positive in the long run. Let's hope the 'buzz' about the pipeline translates into sustained success.